The S&P makes up nearly all of yesterday's lost ground, while Sinovac, Burlington, and ZIOPHARM all rise by double digits.
News & Analysis: Sinovac Biotech
Sinovac, Pluristem, and Synta Pharmaceuticals might all be worth a look today. Let's take a look at the headlines that could move these three stocks.
Sinovac puts a thumping on the lone Wall Street earnings estimate in the second quarter, but are shares now overvalued?
Market-lagging returns could be written in this 1-Star.
A look back at the biggest stories this week in biotech and what they mean for investors.
When is a penny not really a penny?
Or are these just dead cats getting a little air time?
These stocks are reaching for the stars.
Check out these newly minted five-star stocks.